1998
DOI: 10.1016/s0002-9149(98)00322-1
|View full text |Cite
|
Sign up to set email alerts
|

Short communication

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
9
0

Year Published

2003
2003
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 45 publications
(9 citation statements)
references
References 17 publications
0
9
0
Order By: Relevance
“…Elevated resting and exercise blood pressure in the early follicular phase occurred in concert with lower levels of vascular conductance, which suggests that low levels of estrogen also lead to increased peripheral vasoconstriction. The mechanism responsible for the reduced TVC (i.e., enhanced vasoconstriction) may be due to decreases in endothelial function, vascular compliance and nitric oxide availability by low levels of estrogen [1,17,27]. …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Elevated resting and exercise blood pressure in the early follicular phase occurred in concert with lower levels of vascular conductance, which suggests that low levels of estrogen also lead to increased peripheral vasoconstriction. The mechanism responsible for the reduced TVC (i.e., enhanced vasoconstriction) may be due to decreases in endothelial function, vascular compliance and nitric oxide availability by low levels of estrogen [1,17,27]. …”
Section: Discussionmentioning
confidence: 99%
“…Moreover, progesterone levels are low at both of these time points [16]. This was an important consideration, because progesterone can antagonize beneficial effects of estrogen on vascular reactivity [17]. …”
Section: Methodsmentioning
confidence: 99%
“…A number of investigators [3842] have reported that EDD is higher during the follicular phase than either luteal or menstrual phases. The effect of the menstrual cycle on EID has only been reported in two studies [40,41], both reported that there were no significant differences in EID during the different phases of the menstrual cycle. We also did not control for oral contraceptives.…”
Section: Discussionmentioning
confidence: 99%
“…Women with natural menstrual cycles were studied during the early follicular phase (low-hormone phase, days 2–6), and women taking OCs were studied during the placebo phase; this was confirmed by the start of menses 1–5 days prior to study participation. We chose to study women during these phases of the menstrual cycle and OC use due to the varying influences of estrogen and progesterone on MSNA 7, 9, 11, 12 and cardiovascular factors, such as endothelial function, 2630 across the menstrual cycle and/or during the different phases of OC use. In addition, both endogenous estrogen and progesterone concentrations are relatively low during these stages, in contrast to the luteal phase, during which plasma estrogen concentrations are moderate and plasma progesterone concentrations are high.…”
Section: Methodsmentioning
confidence: 99%
“…In addition, both endogenous estrogen and progesterone concentrations are relatively low during these stages, in contrast to the luteal phase, during which plasma estrogen concentrations are moderate and plasma progesterone concentrations are high. 3133 This is important as progesterone may antagonize estrogen’s effects on the vasculature 26 or potentially have an independent influence on MSNA. 34, 35 …”
Section: Methodsmentioning
confidence: 99%